188 related articles for article (PubMed ID: 33713730)
1. Combined in silico and in vitro approaches identified the antipsychotic drug lurasidone and the antiviral drug elbasvir as SARS-CoV2 and HCoV-OC43 inhibitors.
Milani M; Donalisio M; Bonotto RM; Schneider E; Arduino I; Boni F; Lembo D; Marcello A; Mastrangelo E
Antiviral Res; 2021 May; 189():105055. PubMed ID: 33713730
[TBL] [Abstract][Full Text] [Related]
2. Repurposing Nucleoside Analogs for Human Coronaviruses.
Zandi K; Amblard F; Musall K; Downs-Bowen J; Kleinbard R; Oo A; Cao D; Liang B; Russell OO; McBrayer T; Bassit L; Kim B; Schinazi RF
Antimicrob Agents Chemother; 2020 Dec; 65(1):. PubMed ID: 33122172
[TBL] [Abstract][Full Text] [Related]
3. Antiviral Activity of Umifenovir In Vitro against a Broad Spectrum of Coronaviruses, Including the Novel SARS-CoV-2 Virus.
Leneva I; Kartashova N; Poromov A; Gracheva A; Korchevaya E; Glubokova E; Borisova O; Shtro A; Loginova S; Shchukina V; Khamitov R; Faizuloev E
Viruses; 2021 Aug; 13(8):. PubMed ID: 34452529
[TBL] [Abstract][Full Text] [Related]
4. Broad spectrum anti-coronavirus activity of a series of anti-malaria quinoline analogues.
Persoons L; Vanderlinden E; Vangeel L; Wang X; Do NDT; Foo SC; Leyssen P; Neyts J; Jochmans D; Schols D; De Jonghe S
Antiviral Res; 2021 Sep; 193():105127. PubMed ID: 34217752
[TBL] [Abstract][Full Text] [Related]
5. Novel antiviral activity of PAD inhibitors against human beta-coronaviruses HCoV-OC43 and SARS-CoV-2.
Pasquero S; Gugliesi F; Griffante G; Dell'Oste V; Biolatti M; Albano C; Bajetto G; Delbue S; Signorini L; Dolci M; Landolfo S; De Andrea M
Antiviral Res; 2022 Apr; 200():105278. PubMed ID: 35288208
[TBL] [Abstract][Full Text] [Related]
6. Broad-Spectrum Antiviral Activity of 3D8, a Nucleic Acid-Hydrolyzing Single-Chain Variable Fragment (scFv), Targeting SARS-CoV-2 and Multiple Coronaviruses In Vitro.
Lee G; Budhathoki S; Lee GY; Oh KJ; Ham YK; Kim YJ; Lim YR; Hoang PT; Lee Y; Lim SW; Kim JM; Cho S; Kim TH; Song JW; Lee S; Kim WK
Viruses; 2021 Apr; 13(4):. PubMed ID: 33918914
[TBL] [Abstract][Full Text] [Related]
7. Repurposing old drugs as antiviral agents for coronaviruses.
Yang CW; Peng TT; Hsu HY; Lee YZ; Wu SH; Lin WH; Ke YY; Hsu TA; Yeh TK; Huang WZ; Lin JH; Sytwu HK; Chen CT; Lee SJ
Biomed J; 2020 Aug; 43(4):368-374. PubMed ID: 32563698
[TBL] [Abstract][Full Text] [Related]
8. Naphthoquine: A Potent Broad-Spectrum Anti-Coronavirus Drug In Vitro.
Song Y; Deng Y; Wang H; Bei Z; Gu H; Zhao H; Wang H; Zhang D; Xu L; Wang B; Li Y; Wang H
Molecules; 2022 Jan; 27(3):. PubMed ID: 35163977
[TBL] [Abstract][Full Text] [Related]
9. AT-527, a Double Prodrug of a Guanosine Nucleotide Analog, Is a Potent Inhibitor of SARS-CoV-2
Good SS; Westover J; Jung KH; Zhou XJ; Moussa A; La Colla P; Collu G; Canard B; Sommadossi JP
Antimicrob Agents Chemother; 2021 Mar; 65(4):. PubMed ID: 33558299
[TBL] [Abstract][Full Text] [Related]
10. Thapsigargin Is a Broad-Spectrum Inhibitor of Major Human Respiratory Viruses: Coronavirus, Respiratory Syncytial Virus and Influenza A Virus.
Al-Beltagi S; Preda CA; Goulding LV; James J; Pu J; Skinner P; Jiang Z; Wang BL; Yang J; Banyard AC; Mellits KH; Gershkovich P; Hayes CJ; Nguyen-Van-Tam J; Brown IH; Liu J; Chang KC
Viruses; 2021 Feb; 13(2):. PubMed ID: 33546185
[TBL] [Abstract][Full Text] [Related]
11. Activation of STING Signaling Pathway Effectively Blocks Human Coronavirus Infection.
Liu W; Reyes HM; Yang JF; Li Y; Stewart KM; Basil MC; Lin SM; Katzen J; Morrisey EE; Weiss SR; You J
J Virol; 2021 May; 95(12):. PubMed ID: 33789998
[TBL] [Abstract][Full Text] [Related]
12. A high-throughput drug screening strategy against coronaviruses.
Liu J; Li K; Cheng L; Shao J; Yang S; Zhang W; Zhou G; de Vries AAF; Yu Z
Int J Infect Dis; 2021 Feb; 103():300-304. PubMed ID: 33333250
[TBL] [Abstract][Full Text] [Related]
13. High-Throughput Screening and Identification of Potent Broad-Spectrum Inhibitors of Coronaviruses.
Shen L; Niu J; Wang C; Huang B; Wang W; Zhu N; Deng Y; Wang H; Ye F; Cen S; Tan W
J Virol; 2019 Jun; 93(12):. PubMed ID: 30918074
[TBL] [Abstract][Full Text] [Related]
14. IMU-838, a Developmental DHODH Inhibitor in Phase II for Autoimmune Disease, Shows Anti-SARS-CoV-2 and Broad-Spectrum Antiviral Efficacy In Vitro.
Hahn F; Wangen C; Häge S; Peter AS; Dobler G; Hurst B; Julander J; Fuchs J; Ruzsics Z; Überla K; Jäck HM; Ptak R; Muehler A; Gröppel M; Vitt D; Peelen E; Kohlhof H; Marschall M
Viruses; 2020 Dec; 12(12):. PubMed ID: 33291455
[TBL] [Abstract][Full Text] [Related]
15. Cysteamine with In Vitro Antiviral Activity and Immunomodulatory Effects Has the Potential to Be a Repurposing Drug Candidate for COVID-19 Therapy.
Alonzi T; Aiello A; Petrone L; Najafi Fard S; D'Eletto M; Falasca L; Nardacci R; Rossin F; Delogu G; Castilletti C; Capobianchi MR; Ippolito G; Piacentini M; Goletti D
Cells; 2021 Dec; 11(1):. PubMed ID: 35011614
[TBL] [Abstract][Full Text] [Related]
16. Identifying and repurposing antiviral drugs against severe acute respiratory syndrome coronavirus 2 with in silico and in vitro approaches.
Watashi K
Biochem Biophys Res Commun; 2021 Jan; 538():137-144. PubMed ID: 33272566
[TBL] [Abstract][Full Text] [Related]
17. Viral polymerase binding and broad-spectrum antiviral activity of molnupiravir against human seasonal coronaviruses.
Wang Y; Li P; Solanki K; Li Y; Ma Z; Peppelenbosch MP; Baig MS; Pan Q
Virology; 2021 Dec; 564():33-38. PubMed ID: 34619630
[TBL] [Abstract][Full Text] [Related]
18. The rocaglate CR-31-B (-) inhibits SARS-CoV-2 replication at non-cytotoxic, low nanomolar concentrations in vitro and ex vivo.
Müller C; Obermann W; Karl N; Wendel HG; Taroncher-Oldenburg G; Pleschka S; Hartmann RK; Grünweller A; Ziebuhr J
Antiviral Res; 2021 Feb; 186():105012. PubMed ID: 33422611
[TBL] [Abstract][Full Text] [Related]
19. Nsp1 proteins of human coronaviruses HCoV-OC43 and SARS-CoV2 inhibit stress granule formation.
Dolliver SM; Kleer M; Bui-Marinos MP; Ying S; Corcoran JA; Khaperskyy DA
PLoS Pathog; 2022 Dec; 18(12):e1011041. PubMed ID: 36534661
[TBL] [Abstract][Full Text] [Related]
20. EGCG, a green tea polyphenol, inhibits human coronavirus replication in vitro.
Jang M; Park R; Park YI; Cha YE; Yamamoto A; Lee JI; Park J
Biochem Biophys Res Commun; 2021 Apr; 547():23-28. PubMed ID: 33588235
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]